Volume | 316,507 |
|
|||||
News | - | ||||||
Day High | 206.69 | Low High |
|||||
Day Low | 203.28 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Teleflex Inc | TFX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
204.57 | 203.28 | 206.69 | 203.93 | 204.70 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,247 | 316,507 | $ 204.35 | $ 64,678,259 | - | 177.633 - 262.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 45,204 | $ 203.93 | USD |
Teleflex Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.59B | 47.06M | - | 2.98B | 356.33M | 7.57 | 26.92 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Teleflex News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 201.19 | 206.69 | 197.99 | 202.08 | 497,124 | 2.74 | 1.36% |
1 Month | 215.27 | 216.715 | 197.99 | 205.90 | 390,719 | -11.34 | -5.27% |
3 Months | 254.23 | 256.85 | 197.99 | 217.91 | 342,531 | -50.30 | -19.79% |
6 Months | 199.29 | 257.85 | 196.5701 | 226.67 | 281,516 | 4.64 | 2.33% |
1 Year | 253.00 | 262.97 | 177.633 | 224.49 | 288,057 | -49.07 | -19.40% |
3 Years | 412.96 | 428.355 | 177.633 | 272.78 | 332,886 | -209.03 | -50.62% |
5 Years | 299.28 | 449.375 | 177.633 | 299.67 | 295,822 | -95.35 | -31.86% |
Teleflex Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |